Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the Copeptine Dosage in Diagnosis of Post-operative Insipidus Diabetes After Transsphenoidal Pituitary Surgery

NCT04326569 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT04326569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04326569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the Copeptine Dosage in Diagnosis of Post-operative Insipidus Diabetes After Transsphenoidal Pituitary Surgery
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2022
Completion date
March 18, 2024
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary surgery